chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 17 year old female with a kidney condition for which she is being treated who on an unspecified date was vaccinated with Gardasil (lot number unknown) injection. Concomitant medication included diphenhydramine hydrochloride (BENADRYL). About an hour after being vaccinated with Gardasil the patient developed a rash all over her body. Medical attention was sought. The physician advised the patient to take diphenhydramine hydrochloride (BENADRYL) and to follow up with the office if the problem persisted. The patient has not contacted the office yet. The physician reported that it was not an anaphylactic type of reaction. No additional information is provided. Additional information has been requested.
Headache & Myalgia Narrative: Very sore arm starting 1 hours post injection; did not resolve with use of acetaminophen (60mg x2 doses). Felt better in the morning
Pt's arm very sore (L) - had a hard time lifting it. SQ site warm to touch - no elevated temperature. Red around site 1 1/2" - slightly firm. No drainage from site. Encouraged TYLENOL & cool compress to area. Should go to clinic if gets worse. It was better 4 days later.
I have had extreme fatigue and muscle aches/ cramping. I now have low-grade, persistent pain in my feet and ankles. I have spoken with my doctor and I was seen in the emergency room. At no time did I tell anyone it may be related to the vaccine. I was very afraid I would be dismissed, reported, given different treatment, accused of denying the vaccine or Covid-19's impact, or judged negatively by a medical profession with a single mind frame.
no adverse event; improperly stored dose of PEDVAXHIB and ROTATEQ; This spontaneous report was received from a registered nurse referring to an unknown age and gender patient. Pertinent medical history, concomitant medications and drug reactions/allergies were not reported.  On 29-AUG-2022, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, 0.5 milliliter, (strength not provided, lot # W002453 has been verified to be a valid lot number, expiration date reported as 24-JUN-2024) for prophylaxis; and rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 2 milliliter (strength was not provided; lot# 1742465 has been verified to be a valid lot number, expiration date reported as 21-SEP-2022) administered orally for prophylaxis after temperature excursion at 35.7 Fahrenheit (F) for 4 hours 26 minutes (product storage error).There was no previous temperature excursion. No additional adverse events were reported (no adverse event).
Pt had 2 large hives at site of injection, itchy. Pt given Benadryl and hives went down.
This is spontaneous report was received from a physician via two company representatives and from a practice manager (support services director) and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 25-NOV-2014, the patient was vaccinated with an improperly stored dose of GARDASIL injection, lot # K005083, expiration date 04-NOV-2016 (dose, route and site of administration were not reported). The administered dose of vaccine was exposed to temperature excursion (date unspecified) lasting for 48 hours, with the lowest recorded temperature excursion (date unspecified) lasting for 48 hours, with the lowest recorded temperature of 1 degree Fahrenheit (also reported as 1 degree Celsius). The vaccine was stored in a refrigerator. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
4 days after vaccine, had fluttering in chest while sitting watching tv. 5 days after vaccine had fluttering in chest while on treadmill. 7 days after vaccine had fluttering in chest while dressing. Lasted few minutes. No SOB or chest pain.
Patient admitted to hospital with Covid-19 Pneumonia on 02/19/2021. Diagnosed with bronchitis prior week. Having cough and shortness of breath with associated fever x1week
pt rcvd vax; pt was tx w/ dexamethasone sodium phosphate(msd) for achiles tenditis; was tx also w/ medrol dosepak & 3 addtl inject of DSP for chronic bronchitis & pneumonia; lab tests done;
Pt. complained of numbness to left arm within 5 minutes of receiving vaccine administration.   EMS on site.  Pt. reported feeling better within 20 min. and advised to call 911/provider if still having issues.
Patient was at this hospital for brain scans to determine why a sudden exacerbation of Alzheimer's symptoms were occurring.
Had a lot of rash all over the body; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the parent.  A 10 year-old female patient received bnt162b2 (BNT162B2), administered in deltoid right, administration date 28Dec2021 (Lot number: SK5127) at the age of 10 years as dose 1 (tris), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RASH (non-serious) with onset 30Dec2021, outcome "not recovered", described as "Had a lot of rash all over the body". Therapeutic measures were taken as a result of rash.  Additional information: Stated that her daughter had the shot on Tuesday and yesterday she had a lot of rash all over the body and they went to the pharmacy. Treatment: Stated she gave her Benadryl.
Patient came in 4 days after the vaccine and said that her arm swelled up quite a bit. She is doing better now.
Vaccinee exp hives (48 hrs post inject), swollen lip (4 + days post inject) & rash (onset time frame is unk). tx oral Benadryl 50 mg PRN itching (one dose). sx resolved w/in 18 hrs.  Recovered
Client reports pain in arm then loss of hearing, then became hot and faint. Brief loss of consciousness. Client was given ice and told to lie down. Given orange juice to drink. Client recovered with time.
Headache for 33 hours, nausea for 30 hours and Severe chills for 8 hours. Symptoms began about 6 hours after vaccination.
Received the Shingrix Zoster vaccine and the next day had pain, swelling, and redness in/near the location of the shot.
Positive Covid test on 4/5/2021.  Patient received second dose of vaccine on 2/25/21 at same location, Moderna Lot # 011M20A.  Patient has been asymptomatic.
Information has been received from a medical assistant concerning a 63 year old female with chronic obstructive pulmonary disease and amoxicillin allergy and a history of lung cancer who on 04-Sep-2007 was vaccinated SC with a dose of Zostavax (Lot #656858/0356U).  Concomitant therapy included atorvastatin calcium (Lipitor), gabapentin (Neurontin), oxaprozin (Daypro), venlafaxine HC1 (Effexor XR), aluminum hydroxide/magnesiumhydroxide (Maalox), flaxseed, vitamins (unspecified), ascorbic acid (+) chondroitin sulfate sodium (+) glucosamine sulfate (+) manganese (unspecified) (Osteo-Bi-Flex), fexofenadine hydrochloride (Allegra) and acetaminophen (+) propoxyphene napsylate (Darvocet-N).  On approximately 11-Sep-2007, 7 days after vaccination the patient developed an itchy rash and red spots on her legs, inner thighs and torso.  Unspecified medical attention was sought.  No diagnostic laboratory tests were undertaken.  At the time of report the patient had not recovered.  No diagnostic laboratory tests were undertaken.  Additional information has been requested. This is in follow-up to report (s) previously submitted on 12/21/2007. Further information has been received from a physician concerning this 63 years old female who 7 days after being vaccinated with ZOSTAVAX developed an itchy rash. The patient was seen on 17Sep-2007 with multiple papular lesions to the arms legs and buttocks. The patient recovered on 29-SEP-2007. Additional information is not expected.
Sore throat - 1 hr after shot. 5-15 P.M. Also bottom of mouth was swollen in side around 8 PM, called Dr., told me to call 911 and take me to go to hospital. 920 PM. I was given 4 pills at 1145 P.M. BENADRYL, SINGULAR, PEPCID, Petazone.
light headed, dizziness,fatigue, ears ringing, sinus pain, head pains, sore aching neckpain, spinal pain to lwer back, eye pain, some blurry vision, some muscular pain, occaisional chest pains, some vertigo, I am generally ''very active'' outdoors...whenever I attempted to do anything....I had to stop within 2hours.  all this progressed slowly and became very pronounced on July 6th. no change after lots of rest. Finally called doctor.
Patient nausea, heat flashes, sweating, shortness of breath, diarrhea, neck soreness, fainting
daily episodes of fatigue; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team.  A 17 year-old male patient received bnt162b2 (BNT162B2), administration date Aug2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "daily episodes of fatigue". The event "daily episodes of fatigue" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Additional information: the patient was healthy. He received the vaccine 6 weeks ago. He was seen last week in the office and physical exam and lab work was unremarkable as to a reason for the fatigue.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Swelling on the left arm -tricep area from ZOSTAVAX, about Palm-sized in nature.
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. The patient's concurrent conditions, concomitant medication and medical history were not provided. On unknown dates the patients were vaccinated with unspecified doses of improperly stored ROTATEQ (oral, dose and dose number were not provided) (lot # L000571, expiry date 26-JUL-2016). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Awakened 2:00 a.m. (16 hours after vaccine) shivering, teeth chattering, aching all over. Chills 8 more hours, flu-like symptoms kept me home, in bed for next 2 days. All symptoms gone by end of 3rd day. Note: This was 2nd dose, administered at a store. First dose, administered at pharmacy three months prior, no symptoms at all except sore arm.
Dizziness, body ache, lethargic, lump at site of injection for about 5-7 days
After receiving vaccines, redness noted to right arm and hives noted on the knees. Mom stated that she had this reaction at 12 months of age after receiving MMR, Varicella and Hep. A vaccines. A red streak was noted in leg that she received the MMR vaccine in. After the redness and hives noted with vaccines given  02/18/2019, Benadryl was given. No distress noted.
Erythema, swelling, pain, fever, sweats, chills, body aches. Starting later in the day 8/14/06.
The nurse was going to administer a yellow fever and mmr vaccine to client and the same vaccines to client's spouse. The nurse administered the client's mmr dose in the left arm and was supposed to administer the YF dose in the right arm and accidentally grabbed the spouse's mmr dose and administered it instead of the YF dose. Nurse explained the mix up to the client and explained to look for any out of the norm symptoms.
patient reported hives under arms and around stomach area. No swelling or throat closing present. Pt was advised to consult physician of occurrence and to take Benadryl and apply calamine lotion for the itching. Patient was told that if it were to get any worse to seek medical attention for steroid therapy.
Feeling weak; Little lightheaded; Hand where previously patient had surgery is not feeling well; Hot at injection site; Really hard at injection site; Around injection site it is getting redder and bigger; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Feeling weak), DIZZINESS (Little lightheaded), HAND DEFORMITY (Hand where previously patient had surgery is not feeling well), INJECTION SITE WARMTH (Hot at injection site) and INJECTION SITE INDURATION (Really hard at injection site) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced ASTHENIA (Feeling weak), DIZZINESS (Little lightheaded), HAND DEFORMITY (Hand where previously patient had surgery is not feeling well), INJECTION SITE WARMTH (Hot at injection site), INJECTION SITE INDURATION (Really hard at injection site) and VACCINATION SITE ERYTHEMA (Around injection site it is getting redder and bigger). At the time of the report, ASTHENIA (Feeling weak), DIZZINESS (Little lightheaded), HAND DEFORMITY (Hand where previously patient had surgery is not feeling well), INJECTION SITE WARMTH (Hot at injection site), INJECTION SITE INDURATION (Really hard at injection site) and VACCINATION SITE ERYTHEMA (Around injection site it is getting redder and bigger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications and treatment information were reported.
Information has been received from a certified medical assistant concerning an unspecified patient (unknown age and gender). The patient's pertinent medical history and concurrent conditions were not informed. It was reported that on 27-SEP-2016, the patient was administered an improperly stored dose of VARIVAX lot # M025867, expiration date 24-MAY-2018, (dosage was not provided), administered per subcutaneous route. Concomitant therapies were not informed. No adverse effects were reported. No product quality complaint (PQC) was involved. Additional information has been requested.
Narrative:  70 yo female received her first dose of the Covid (Pfizer) vaccine in March 2021. She reported fatigue and myalgias for two days following the administration, but the symptoms resolved. About a month later, she received the second dose of the series, but no symptoms were reported.
Within a few hours, both legs broke out in a swollen, painful rash that lasted for weeks.
17OCT90 rec'd 1st Engerix-B inject @ 930AM; @2PM extreme vertigo & nausea. @ 430 PM immobilized due to dizziness. Movement of head & neck extremely painful. Duration approx 24 hrs; 3 additional episodes of vertigo @ 3 wks, lasting 1-1.5hrs.
Shingrix adjuvant only without the lyophilized antigen; Shingrix adjuvant only without the lyophilized antigen; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received a dose of the Shingrix adjuvant only without the lyophilized antigen, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. No symptoms reported. The reporter was not in the office at the time of report and did not have any of the patient's information at that time. The reporter consented to follow up. This case was 1 of 12 linked cases, reported by same reporter for different patients.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR179303:Same reporter US-GLAXOSMITHKLINE-US2021AMR179302:Same reporter US-GLAXOSMITHKLINE-US2021AMR179304:Same reporter US-GLAXOSMITHKLINE-US2021AMR179297:Same reporter US-GLAXOSMITHKLINE-US2021AMR179299:Same reporter US-GLAXOSMITHKLINE-US2021AMR179307:Same reporter US-GLAXOSMITHKLINE-US2021AMR179306:Same reporter US-GLAXOSMITHKLINE-US2021AMR179298:Same reporter US-GLAXOSMITHKLINE-US2021AMR179300:Same reporter US-GLAXOSMITHKLINE-US2021AMR179301:Same reporter US-GLAXOSMITHKLINE-US2021178442:Same reporter
fainting spell lasting 2mins-clonic tonic activity noted-slow to arouse; vitals stable referred to ER for immed treatment; no PHM of sz;
Patient reports chills and nausea which started the evening of the vaccine and last 24 hours.  She also reports a persistent headache that lasted for 3 days and that she missed work for a total of seven days.
tiredness; fever; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (tiredness) and PYREXIA (fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 prophylaxis.     It was reported that patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (tiredness) and PYREXIA (fever). At the time of the report, FATIGUE (tiredness) and PYREXIA (fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. It was reported that patient received second dose on 27-Mar-2021 039A21A, third dose on 03-Nov-2021 66F21A and 4th dose on 05-Apr-2022 048L21A. Patient experienced side effects with her previous doses. After first dose her arm didn´t swell up until 8 days after the vaccine. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-746975 (Patient Link).
Body started itching; This is a spontaneous report from a contactable consumer (patient).  A 55-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686), via an unspecified route of administration on 05Jan2021 at single dose for COVID-19 immunization. The patient medical history was none.  The patient's concomitant medications were not reported. On Jan2021, the patient reported that: "my body started itching but I didn't have any rash or anything like that. I am still itching some but not as much. I have been taking BENADRYL, 50 mg". The patient outcome of the event was not recovered.
PT PRESENTED TO ALLERGY/IMMUNIZATIONS CLINIC C/O A 5 DAY RASH OVER BOTH ARMS AND INSIDE OF THIGHS.  PT BELIEVES IT MAY HAVE POSSBILY COME FROM THE SMALLPOX VACCINE.  PROVIDER EXAMINED PT, TOLD TO RETURN IF S/S GET WORSE OR ANY ADDITIONAL S/S DEVELOP.  NO TREATMENT WAS GIVEN.
myocarditis with chest pain 2 days after 2nd dose, patient left AMA
pt found by parent not breathing, CPR started, transported to nearest ER on 21FEB99, unable to resuscitate;
Received pneumococcal 23 vaccine at physician office on 10/13/2017. Experienced severe swelling, redness, rash, fever, fluid retention in the right arm where the shot was administered. Pain and fluid retention included the upper arm, shoulder joint, and elbow areas. Some confusion consistent with fever noticed. Severe pain and swelling lasted 4 days. Rash and discomfort continued longer. This reaction occurred in a healthy, active 74 year old woman.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 03-Feb-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 03-Feb-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 03-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 03-Feb-2022) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2022 at 3:01 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 03-Feb-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 03-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 03-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 03-Feb-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The patient had received the vaccine dose number as booster.  No concomitant medications were reported.  It was reported that the booster vaccine was administered 30 days past expiry date.   No treatment medications were reported.   This case was linked to MOD-2022-542869 (Patient Link).
18JUL crying wouldn't step w/rt leg-2 episodes that lasted aobut 10 mins-about 1 hr apart; 19JUL 7AM limping & fever of 102.2;
Pt presented after vaccine couple hrs after with shoulder pain and large swollen tricep at 24 inches wide, hard around edges. No other symptom. Pt on way to doctors.